The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions
Paola Zaratin(Associazione Italiana Sclerosi Multipla), Gıancarlo Comı(Vita-Salute San Raffaele University), Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam), Gavin Giovannoni(Queen Mary University of London), Peer Baneke(Multiple Sclerosis International Federation), Giampaolo Brichetto(Associazione Italiana Sclerosi Multipla), Anne Helme(Multiple Sclerosis International Federation), Patrick Vermersch(Université de Lille), Usman A. Khan(KU Leuven), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Gary Cutter(Alabama Department of Public Health), Timothy Coetzee(National Multiple Sclerosis Society), LG Mantovani(Unknown), Iris‐Katharina Penner(University of Bern), Letizia Leocani(Vita-Salute San Raffaele University), Maria Pia Amato(Don Carlo Gnocchi Foundation), Robert McBurney(Accelerated Cure Project for Multiple Sclerosis), Pamela Valentine(Multiple Sclerosis Society of Canada), Robert Hyde(Biogen (Switzerland)), Deborah Bertorello(Associazione Italiana Sclerosi Multipla), Helga Weiland, Hans Hartung(Heinrich Heine University Düsseldorf), Mario Alberto Battaglia(University of Siena), Emma Gray(Wellcome Sanger Institute), Gilles Edan, Jeremy Hobart(Peninsula College of Medicine and Dentistry)
Cited by 40
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k